-Advertisement-

CCP Approves CDC’s Investment in NCMCL Under Competition Act Review

- Advertisement -

Approves CDC’s Investment in NCMCL

The (CCP) has approved the proposed investment by the Central Depository Company of Pakistan Limited (CDC) in Naymat Collateral Management Company Limited (NCMCL). This decision follows a Phase-I review under the Competition Act, 2010.

- Advertisement -

CDC submitted a pre-merger application to the CCP seeking approval for additional shareholding in NCMCL. The Commission’s competition assessment concluded that the transaction would not significantly alter competition dynamics as CDC and NCMCL operate in separate business segments.

Founded in 1993, CDC is one of Pakistan’s key capital market institutions providing electronic custody of securities and settlement facilitation services. Established in 2020, NCMCL operates as a collateral management company overseeing warehouses under the Electronic Warehouse Receipt framework.

The CCP’s decision reflects its commitment to facilitating investment while ensuring competition and consumer welfare are protected.

- Advertisement -

Stay updated with the latest and breaking news directly on your mobile phone by joining Headline PK's WhatsApp group!

 

 

Latest stories

-Advertisement-

Highlights of the Week
Related

SIMPACT 2026 Brings AI to the Forefront of Simulation Education

The Aga Khan University's (AKU) Centre for Innovation in...

Meezan Bank Continues Blood Donation Drive in Partnership with The Indus Hospital

Meezan Bank, Pakistan's premier Islamic bank, once again partnered...
-Advertisement-